¾ÅÐãÖ±²¥ Vice-Principal Research¾ÅÐãÖ±²¥ Partnerships and Innovation is pleased to announce the issuance of Japanese Patent No. 7462569 "Compounds and Methods for Inhibiting CYP26 Enzymes" on March 28, 2024 to Donald Cameron, Martin Petkovich, and Uttam Saha. The patent relates to Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes and have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids